Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of HSK39297 tablets in Chinese adults with primary IgA nephropathy
CTR20260278Phase 3Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprocopan in IgA nephropathy (IgAN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Apr 2026; status: active.
02
Drugs
ciprocopan
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on CTR20260278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260278.